Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Anti-PD-1/VEGF BsAb by 3SBio for Gynecological Cancer: Likelihood of Approval
Anti-PD-1/VEGF BsAb is under clinical development by 3SBio and currently in Phase II for Gynecological Cancer. According to GlobalData, Phase...